Baxter Healthcare Corporation's BioPharma Solutions business offers contract services and proprietary technologies focused on parenteral delivery.
The company has partnered with more than 150 clients, including the leading pharmaceutical and biopharmaceutical companies.
Participated at Bio/PharMOS & Bio/PharDOS
Objective : We are actively pursuing co-development opportunities, out-licensing of internally developed products, strategic and/or full development programs.
About Baxter Healthcare Corporation : Baxter's contract services include process development of biologic API; form/fill/finish of drug product into syringes, vials and cartridges; and cytotoxic chemical synthesis (API) to scale-up for commercial production.
Our Bloomington, Indiana facility has expanded capacities for syringe and vial filling/finishing and for lyophilization at the newly established Lyophilization Center of Excellence. New capability in cartridge filling/finishing and fully automated kitting has been added.
Proprietary technologies include formulation: NANOEDGE dispersion technology for solubility challenges and PROMAXX protein microsphere technology for controlled release; and Ready-To-Use and Ready-To-Mix products that can help extend the life of your product after patent expiry.
Activities
